nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Sulfasalazine—Crohn's disease	0.0303	0.546	CbGbCtD
Boceprevir—CTSL—mouth—Crohn's disease	0.017	0.0597	CbGeAlD
Boceprevir—ABCB1—Prednisone—Crohn's disease	0.0158	0.284	CbGbCtD
Boceprevir—CTSK—gall bladder—Crohn's disease	0.0144	0.0506	CbGeAlD
Boceprevir—CTSK—mouth—Crohn's disease	0.0128	0.045	CbGeAlD
Boceprevir—CTSS—gall bladder—Crohn's disease	0.0126	0.0443	CbGeAlD
Boceprevir—CTSL—Carbidopa—Mesalazine—Crohn's disease	0.0118	0.876	CbGdCrCtD
Boceprevir—CTSV—skin of body—Crohn's disease	0.0115	0.0404	CbGeAlD
Boceprevir—CTSS—mouth—Crohn's disease	0.0112	0.0394	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—Crohn's disease	0.0111	0.0391	CbGeAlD
Boceprevir—CMA1—skin of body—Crohn's disease	0.011	0.0386	CbGeAlD
Boceprevir—CTSV—mammalian vulva—Crohn's disease	0.0105	0.0369	CbGeAlD
Boceprevir—CMA1—mammalian vulva—Crohn's disease	0.01	0.0352	CbGeAlD
Boceprevir—CTSL—epithelium—Crohn's disease	0.00988	0.0347	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—Crohn's disease	0.00952	0.0335	CbGeAlD
Boceprevir—CYP3A4—Prednisone—Crohn's disease	0.00946	0.17	CbGbCtD
Boceprevir—CTSL—skin of body—Crohn's disease	0.0094	0.033	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—Crohn's disease	0.00932	0.0327	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—Crohn's disease	0.0089	0.0313	CbGeAlD
Boceprevir—CMA1—digestive system—Crohn's disease	0.00879	0.0309	CbGeAlD
Boceprevir—CTSL—mammalian vulva—Crohn's disease	0.00857	0.0301	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—Crohn's disease	0.00761	0.0267	CbGeAlD
Boceprevir—CTSL—digestive system—Crohn's disease	0.00752	0.0264	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—Crohn's disease	0.00718	0.0252	CbGeAlD
Boceprevir—CTSK—skin of body—Crohn's disease	0.00708	0.0249	CbGeAlD
Boceprevir—CTSK—mammalian vulva—Crohn's disease	0.00646	0.0227	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—Crohn's disease	0.00629	0.0221	CbGeAlD
Boceprevir—CTSS—skin of body—Crohn's disease	0.00621	0.0218	CbGeAlD
Boceprevir—Telaprevir—ALB—Crohn's disease	0.00606	1	CrCbGaD
Boceprevir—CTSK—lymphoid tissue—Crohn's disease	0.00574	0.0202	CbGeAlD
Boceprevir—CTSK—digestive system—Crohn's disease	0.00567	0.0199	CbGeAlD
Boceprevir—CTSS—mammalian vulva—Crohn's disease	0.00566	0.0199	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—Crohn's disease	0.00503	0.0177	CbGeAlD
Boceprevir—CMA1—lymph node—Crohn's disease	0.00502	0.0176	CbGeAlD
Boceprevir—CTSS—digestive system—Crohn's disease	0.00496	0.0174	CbGeAlD
Boceprevir—CTSL—lymph node—Crohn's disease	0.00429	0.0151	CbGeAlD
Boceprevir—CTSK—lymph node—Crohn's disease	0.00324	0.0114	CbGeAlD
Boceprevir—CTSS—lymph node—Crohn's disease	0.00284	0.00996	CbGeAlD
Boceprevir—CYP3A5—digestive system—Crohn's disease	0.00165	0.00579	CbGeAlD
Boceprevir—Alopecia—Mercaptopurine—Crohn's disease	0.00147	0.00413	CcSEcCtD
Boceprevir—Deafness—Mesalazine—Crohn's disease	0.00146	0.00409	CcSEcCtD
Boceprevir—Eczema—Mesalazine—Crohn's disease	0.00145	0.00408	CcSEcCtD
Boceprevir—Blood triglycerides increased—Prednisone—Crohn's disease	0.00145	0.00407	CcSEcCtD
Boceprevir—Malnutrition—Mercaptopurine—Crohn's disease	0.00145	0.00406	CcSEcCtD
Boceprevir—Eye pain—Mesalazine—Crohn's disease	0.00145	0.00406	CcSEcCtD
Boceprevir—Atrial fibrillation—Mesalazine—Crohn's disease	0.00138	0.00387	CcSEcCtD
Boceprevir—Suicidal ideation—Prednisone—Crohn's disease	0.00136	0.00381	CcSEcCtD
Boceprevir—Arthritis—Mesalazine—Crohn's disease	0.00134	0.00377	CcSEcCtD
Boceprevir—Anaemia—Mercaptopurine—Crohn's disease	0.00134	0.00376	CcSEcCtD
Boceprevir—Lethargy—Mesalazine—Crohn's disease	0.00133	0.00374	CcSEcCtD
Boceprevir—Leukopenia—Mercaptopurine—Crohn's disease	0.0013	0.00364	CcSEcCtD
Boceprevir—Migraine—Mesalazine—Crohn's disease	0.00129	0.00361	CcSEcCtD
Boceprevir—Affect lability—Mesalazine—Crohn's disease	0.00129	0.00361	CcSEcCtD
Boceprevir—Mood swings—Mesalazine—Crohn's disease	0.00124	0.00347	CcSEcCtD
Boceprevir—CYP3A4—digestive system—Crohn's disease	0.00124	0.00435	CbGeAlD
Boceprevir—Arthralgia—Mercaptopurine—Crohn's disease	0.00123	0.00346	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00123	0.00344	CcSEcCtD
Boceprevir—Pancreatitis—Azathioprine—Crohn's disease	0.00122	0.00341	CcSEcCtD
Boceprevir—Memory impairment—Prednisone—Crohn's disease	0.00121	0.0034	CcSEcCtD
Boceprevir—Dry skin—Mesalazine—Crohn's disease	0.0012	0.00336	CcSEcCtD
Boceprevir—Abdominal pain upper—Mesalazine—Crohn's disease	0.00119	0.00335	CcSEcCtD
Boceprevir—Abdominal discomfort—Azathioprine—Crohn's disease	0.00119	0.00333	CcSEcCtD
Boceprevir—Breast disorder—Mesalazine—Crohn's disease	0.00118	0.00331	CcSEcCtD
Boceprevir—Pancytopenia—Azathioprine—Crohn's disease	0.00118	0.0033	CcSEcCtD
Boceprevir—Nasopharyngitis—Mesalazine—Crohn's disease	0.00117	0.00328	CcSEcCtD
Boceprevir—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00116	0.00325	CcSEcCtD
Boceprevir—Gastritis—Mesalazine—Crohn's disease	0.00116	0.00324	CcSEcCtD
Boceprevir—ABCB1—epithelium—Crohn's disease	0.00115	0.00404	CbGeAlD
Boceprevir—Skin disorder—Mercaptopurine—Crohn's disease	0.00115	0.00322	CcSEcCtD
Boceprevir—Endocrine disorder—Prednisone—Crohn's disease	0.00115	0.00322	CcSEcCtD
Boceprevir—Abdominal distension—Mesalazine—Crohn's disease	0.00114	0.00319	CcSEcCtD
Boceprevir—Dysphagia—Mesalazine—Crohn's disease	0.00113	0.00317	CcSEcCtD
Boceprevir—Influenza—Mesalazine—Crohn's disease	0.00113	0.00317	CcSEcCtD
Boceprevir—Eosinophilia—Mesalazine—Crohn's disease	0.00112	0.00313	CcSEcCtD
Boceprevir—Pneumonia—Azathioprine—Crohn's disease	0.00111	0.00312	CcSEcCtD
Boceprevir—Pancreatitis—Mesalazine—Crohn's disease	0.00111	0.0031	CcSEcCtD
Boceprevir—Infestation—Azathioprine—Crohn's disease	0.00111	0.0031	CcSEcCtD
Boceprevir—Infestation NOS—Azathioprine—Crohn's disease	0.00111	0.0031	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0011	0.00307	CcSEcCtD
Boceprevir—Bronchitis—Mesalazine—Crohn's disease	0.00109	0.00304	CcSEcCtD
Boceprevir—Amenorrhoea—Prednisone—Crohn's disease	0.00108	0.00304	CcSEcCtD
Boceprevir—Abdominal discomfort—Mesalazine—Crohn's disease	0.00108	0.00304	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00108	0.00302	CcSEcCtD
Boceprevir—Pancytopenia—Mesalazine—Crohn's disease	0.00107	0.00301	CcSEcCtD
Boceprevir—Neutropenia—Mesalazine—Crohn's disease	0.00106	0.00296	CcSEcCtD
Boceprevir—Dysuria—Mesalazine—Crohn's disease	0.00106	0.00296	CcSEcCtD
Boceprevir—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00105	0.00293	CcSEcCtD
Boceprevir—Pollakiuria—Mesalazine—Crohn's disease	0.00104	0.00292	CcSEcCtD
Boceprevir—Agranulocytosis—Azathioprine—Crohn's disease	0.00103	0.00289	CcSEcCtD
Boceprevir—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00103	0.00289	CcSEcCtD
Boceprevir—Decreased appetite—Mercaptopurine—Crohn's disease	0.00103	0.00288	CcSEcCtD
Boceprevir—Weight decreased—Mesalazine—Crohn's disease	0.00102	0.00286	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00102	0.00286	CcSEcCtD
Boceprevir—Pneumonia—Mesalazine—Crohn's disease	0.00101	0.00284	CcSEcCtD
Boceprevir—Infestation NOS—Mesalazine—Crohn's disease	0.00101	0.00282	CcSEcCtD
Boceprevir—Infestation—Mesalazine—Crohn's disease	0.00101	0.00282	CcSEcCtD
Boceprevir—Depression—Mesalazine—Crohn's disease	0.001	0.00281	CcSEcCtD
Boceprevir—ABCB1—mammalian vulva—Crohn's disease	0.000999	0.00351	CbGeAlD
Boceprevir—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000998	0.0028	CcSEcCtD
Boceprevir—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000987	0.00277	CcSEcCtD
Boceprevir—Stomatitis—Mesalazine—Crohn's disease	0.000981	0.00275	CcSEcCtD
Boceprevir—Conjunctivitis—Mesalazine—Crohn's disease	0.000979	0.00274	CcSEcCtD
Boceprevir—Urinary tract infection—Mesalazine—Crohn's disease	0.000979	0.00274	CcSEcCtD
Boceprevir—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000952	0.00267	CcSEcCtD
Boceprevir—Epistaxis—Mesalazine—Crohn's disease	0.00095	0.00266	CcSEcCtD
Boceprevir—Sinusitis—Mesalazine—Crohn's disease	0.000945	0.00265	CcSEcCtD
Boceprevir—Agranulocytosis—Mesalazine—Crohn's disease	0.00094	0.00263	CcSEcCtD
Boceprevir—Erythema multiforme—Azathioprine—Crohn's disease	0.000938	0.00263	CcSEcCtD
Boceprevir—Body temperature increased—Mercaptopurine—Crohn's disease	0.000935	0.00262	CcSEcCtD
Boceprevir—Rhinitis—Mesalazine—Crohn's disease	0.000906	0.00254	CcSEcCtD
Boceprevir—Pharyngitis—Mesalazine—Crohn's disease	0.000897	0.00252	CcSEcCtD
Boceprevir—Immune system disorder—Azathioprine—Crohn's disease	0.000896	0.00251	CcSEcCtD
Boceprevir—Mediastinal disorder—Azathioprine—Crohn's disease	0.000894	0.00251	CcSEcCtD
Boceprevir—Urinary tract disorder—Mesalazine—Crohn's disease	0.000893	0.0025	CcSEcCtD
Boceprevir—Oedema peripheral—Mesalazine—Crohn's disease	0.00089	0.0025	CcSEcCtD
Boceprevir—Chills—Azathioprine—Crohn's disease	0.00089	0.0025	CcSEcCtD
Boceprevir—Connective tissue disorder—Mesalazine—Crohn's disease	0.000888	0.00249	CcSEcCtD
Boceprevir—ABCB1—lymphoid tissue—Crohn's disease	0.000887	0.00311	CbGeAlD
Boceprevir—Arrhythmia—Azathioprine—Crohn's disease	0.000886	0.00249	CcSEcCtD
Boceprevir—Urethral disorder—Mesalazine—Crohn's disease	0.000886	0.00248	CcSEcCtD
Boceprevir—Alopecia—Azathioprine—Crohn's disease	0.000877	0.00246	CcSEcCtD
Boceprevir—ABCB1—digestive system—Crohn's disease	0.000876	0.00308	CbGeAlD
Boceprevir—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000872	0.00244	CcSEcCtD
Boceprevir—Erythema multiforme—Mesalazine—Crohn's disease	0.000855	0.0024	CcSEcCtD
Boceprevir—Eye disorder—Mesalazine—Crohn's disease	0.000845	0.00237	CcSEcCtD
Boceprevir—Tinnitus—Mesalazine—Crohn's disease	0.000843	0.00236	CcSEcCtD
Boceprevir—Cardiac disorder—Mesalazine—Crohn's disease	0.000839	0.00235	CcSEcCtD
Boceprevir—CTSL—Betamethasone—Prednisone—Crohn's disease	0.000832	0.0618	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisone—Crohn's disease	0.000832	0.0618	CbGdCrCtD
Boceprevir—Sepsis—Prednisone—Crohn's disease	0.000826	0.00232	CcSEcCtD
Boceprevir—Angiopathy—Mesalazine—Crohn's disease	0.00082	0.0023	CcSEcCtD
Boceprevir—Immune system disorder—Mesalazine—Crohn's disease	0.000816	0.00229	CcSEcCtD
Boceprevir—Mediastinal disorder—Mesalazine—Crohn's disease	0.000815	0.00228	CcSEcCtD
Boceprevir—Chills—Mesalazine—Crohn's disease	0.000811	0.00227	CcSEcCtD
Boceprevir—Diarrhoea—Mercaptopurine—Crohn's disease	0.00081	0.00227	CcSEcCtD
Boceprevir—Ill-defined disorder—Azathioprine—Crohn's disease	0.000801	0.00225	CcSEcCtD
Boceprevir—Alopecia—Mesalazine—Crohn's disease	0.000799	0.00224	CcSEcCtD
Boceprevir—Anaemia—Azathioprine—Crohn's disease	0.000798	0.00224	CcSEcCtD
Boceprevir—Diabetes mellitus—Prednisone—Crohn's disease	0.000795	0.00223	CcSEcCtD
Boceprevir—Mental disorder—Mesalazine—Crohn's disease	0.000792	0.00222	CcSEcCtD
Boceprevir—Erythema—Mesalazine—Crohn's disease	0.000787	0.00221	CcSEcCtD
Boceprevir—Malaise—Azathioprine—Crohn's disease	0.000779	0.00218	CcSEcCtD
Boceprevir—Flatulence—Mesalazine—Crohn's disease	0.000775	0.00217	CcSEcCtD
Boceprevir—Leukopenia—Azathioprine—Crohn's disease	0.000773	0.00217	CcSEcCtD
Boceprevir—Dysgeusia—Mesalazine—Crohn's disease	0.00077	0.00216	CcSEcCtD
Boceprevir—Back pain—Mesalazine—Crohn's disease	0.000761	0.00213	CcSEcCtD
Boceprevir—Muscle spasms—Mesalazine—Crohn's disease	0.000756	0.00212	CcSEcCtD
Boceprevir—Vomiting—Mercaptopurine—Crohn's disease	0.000752	0.00211	CcSEcCtD
Boceprevir—Rash—Mercaptopurine—Crohn's disease	0.000746	0.00209	CcSEcCtD
Boceprevir—Dermatitis—Mercaptopurine—Crohn's disease	0.000745	0.00209	CcSEcCtD
Boceprevir—Vision blurred—Mesalazine—Crohn's disease	0.000742	0.00208	CcSEcCtD
Boceprevir—Amnesia—Prednisone—Crohn's disease	0.000736	0.00206	CcSEcCtD
Boceprevir—Myalgia—Azathioprine—Crohn's disease	0.000735	0.00206	CcSEcCtD
Boceprevir—Arthralgia—Azathioprine—Crohn's disease	0.000735	0.00206	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00073	0.00205	CcSEcCtD
Boceprevir—Ill-defined disorder—Mesalazine—Crohn's disease	0.00073	0.00205	CcSEcCtD
Boceprevir—Anaemia—Mesalazine—Crohn's disease	0.000727	0.00204	CcSEcCtD
Boceprevir—Discomfort—Azathioprine—Crohn's disease	0.000727	0.00204	CcSEcCtD
Boceprevir—Angioedema—Mesalazine—Crohn's disease	0.000719	0.00202	CcSEcCtD
Boceprevir—Malaise—Mesalazine—Crohn's disease	0.00071	0.00199	CcSEcCtD
Boceprevir—Vertigo—Mesalazine—Crohn's disease	0.000707	0.00198	CcSEcCtD
Boceprevir—Syncope—Mesalazine—Crohn's disease	0.000706	0.00198	CcSEcCtD
Boceprevir—Lethargy—Prednisone—Crohn's disease	0.000705	0.00198	CcSEcCtD
Boceprevir—Leukopenia—Mesalazine—Crohn's disease	0.000704	0.00197	CcSEcCtD
Boceprevir—Nausea—Mercaptopurine—Crohn's disease	0.000703	0.00197	CcSEcCtD
Boceprevir—Infection—Azathioprine—Crohn's disease	0.0007	0.00196	CcSEcCtD
Boceprevir—Palpitations—Mesalazine—Crohn's disease	0.000695	0.00195	CcSEcCtD
Boceprevir—Loss of consciousness—Mesalazine—Crohn's disease	0.000692	0.00194	CcSEcCtD
Boceprevir—Thrombocytopenia—Azathioprine—Crohn's disease	0.00069	0.00194	CcSEcCtD
Boceprevir—Cough—Mesalazine—Crohn's disease	0.000687	0.00192	CcSEcCtD
Boceprevir—Skin disorder—Azathioprine—Crohn's disease	0.000685	0.00192	CcSEcCtD
Boceprevir—Affect lability—Prednisone—Crohn's disease	0.00068	0.00191	CcSEcCtD
Boceprevir—Hypertension—Mesalazine—Crohn's disease	0.000679	0.0019	CcSEcCtD
Boceprevir—Psychotic disorder—Prednisone—Crohn's disease	0.000675	0.00189	CcSEcCtD
Boceprevir—Arthralgia—Mesalazine—Crohn's disease	0.00067	0.00188	CcSEcCtD
Boceprevir—Chest pain—Mesalazine—Crohn's disease	0.00067	0.00188	CcSEcCtD
Boceprevir—Myalgia—Mesalazine—Crohn's disease	0.00067	0.00188	CcSEcCtD
Boceprevir—Anxiety—Mesalazine—Crohn's disease	0.000668	0.00187	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000665	0.00187	CcSEcCtD
Boceprevir—Discomfort—Mesalazine—Crohn's disease	0.000662	0.00186	CcSEcCtD
Boceprevir—Irritability—Prednisone—Crohn's disease	0.00066	0.00185	CcSEcCtD
Boceprevir—Hypotension—Azathioprine—Crohn's disease	0.000659	0.00185	CcSEcCtD
Boceprevir—Dry mouth—Mesalazine—Crohn's disease	0.000655	0.00184	CcSEcCtD
Boceprevir—Mood swings—Prednisone—Crohn's disease	0.000655	0.00184	CcSEcCtD
Boceprevir—Confusional state—Mesalazine—Crohn's disease	0.000647	0.00182	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—ITGA4—Crohn's disease	0.000645	0.00227	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ITGA4—Crohn's disease	0.000645	0.00227	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—RIPK2—Crohn's disease	0.000645	0.00227	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RIPK2—Crohn's disease	0.000645	0.00227	CbGpPWpGaD
Boceprevir—CTSS—Immune System—DEFA5—Crohn's disease	0.000643	0.00227	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNGR2—Crohn's disease	0.000643	0.00227	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000642	0.0018	CcSEcCtD
Boceprevir—Infection—Mesalazine—Crohn's disease	0.000638	0.00179	CcSEcCtD
Boceprevir—CTSK—Immune System—CARD9—Crohn's disease	0.000636	0.00224	CbGpPWpGaD
Boceprevir—Dry skin—Prednisone—Crohn's disease	0.000634	0.00178	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—RASGRP1—Crohn's disease	0.000633	0.00223	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—RASGRP1—Crohn's disease	0.000633	0.00223	CbGpPWpGaD
Boceprevir—Shock—Mesalazine—Crohn's disease	0.000632	0.00177	CcSEcCtD
Boceprevir—Nervous system disorder—Mesalazine—Crohn's disease	0.00063	0.00177	CcSEcCtD
Boceprevir—Hypokalaemia—Prednisone—Crohn's disease	0.000629	0.00176	CcSEcCtD
Boceprevir—Thrombocytopenia—Mesalazine—Crohn's disease	0.000629	0.00176	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—RBX1—Crohn's disease	0.000629	0.00222	CbGpPWpGaD
Boceprevir—Tachycardia—Mesalazine—Crohn's disease	0.000627	0.00176	CcSEcCtD
Boceprevir—Skin disorder—Mesalazine—Crohn's disease	0.000624	0.00175	CcSEcCtD
Boceprevir—Hyperhidrosis—Mesalazine—Crohn's disease	0.000621	0.00174	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—TAB1—Crohn's disease	0.00062	0.00219	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TAB1—Crohn's disease	0.00062	0.00219	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ICAM1—Crohn's disease	0.000616	0.00217	CbGpPWpGaD
Boceprevir—Muscular weakness—Prednisone—Crohn's disease	0.00061	0.00171	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—TAGAP—Crohn's disease	0.000609	0.00215	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NOD2—Crohn's disease	0.000609	0.00215	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NOD2—Crohn's disease	0.000609	0.00215	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000609	0.00171	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—RASGRP1—Crohn's disease	0.000608	0.00214	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—RASGRP1—Crohn's disease	0.000608	0.00214	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—Crohn's disease	0.000606	0.00214	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—Crohn's disease	0.000606	0.00214	CbGpPWpGaD
Boceprevir—Abdominal distension—Prednisone—Crohn's disease	0.000601	0.00169	CcSEcCtD
Boceprevir—Hypotension—Mesalazine—Crohn's disease	0.0006	0.00168	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CCR6—Crohn's disease	0.000596	0.0021	CbGpPWpGaD
Boceprevir—Pancreatitis—Prednisone—Crohn's disease	0.000586	0.00164	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000585	0.00164	CcSEcCtD
Boceprevir—Feeling abnormal—Azathioprine—Crohn's disease	0.000581	0.00163	CcSEcCtD
Boceprevir—Insomnia—Mesalazine—Crohn's disease	0.000581	0.00163	CcSEcCtD
Boceprevir—Paraesthesia—Mesalazine—Crohn's disease	0.000577	0.00162	CcSEcCtD
Boceprevir—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000576	0.00162	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—SOCS1—Crohn's disease	0.000574	0.00202	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—SOCS1—Crohn's disease	0.000574	0.00202	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—UBE2D1—Crohn's disease	0.000574	0.00202	CbGpPWpGaD
Boceprevir—Dyspnoea—Mesalazine—Crohn's disease	0.000572	0.00161	CcSEcCtD
Boceprevir—Dyspepsia—Mesalazine—Crohn's disease	0.000565	0.00158	CcSEcCtD
Boceprevir—CTSL—Immune System—NOD1—Crohn's disease	0.00056	0.00198	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NOD1—Crohn's disease	0.00056	0.00198	CbGpPWpGaD
Boceprevir—Neutropenia—Prednisone—Crohn's disease	0.000559	0.00157	CcSEcCtD
Boceprevir—Decreased appetite—Mesalazine—Crohn's disease	0.000558	0.00157	CcSEcCtD
Boceprevir—Abdominal pain—Azathioprine—Crohn's disease	0.000557	0.00156	CcSEcCtD
Boceprevir—Body temperature increased—Azathioprine—Crohn's disease	0.000557	0.00156	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—RIPK2—Crohn's disease	0.000557	0.00196	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000554	0.00155	CcSEcCtD
Boceprevir—Fatigue—Mesalazine—Crohn's disease	0.000554	0.00155	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—SOCS1—Crohn's disease	0.000551	0.00194	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—UBE2D1—Crohn's disease	0.000551	0.00194	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—SOCS1—Crohn's disease	0.000551	0.00194	CbGpPWpGaD
Boceprevir—Erectile dysfunction—Prednisone—Crohn's disease	0.00055	0.00154	CcSEcCtD
Boceprevir—Pain—Mesalazine—Crohn's disease	0.000549	0.00154	CcSEcCtD
Boceprevir—Constipation—Mesalazine—Crohn's disease	0.000549	0.00154	CcSEcCtD
Boceprevir—Weight decreased—Prednisone—Crohn's disease	0.000541	0.00152	CcSEcCtD
Boceprevir—Hyperglycaemia—Prednisone—Crohn's disease	0.000539	0.00151	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—RIPK2—Crohn's disease	0.000534	0.00188	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ITGA4—Crohn's disease	0.000534	0.00188	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RSPO3—Crohn's disease	0.000532	0.00188	CbGpPWpGaD
Boceprevir—Depression—Prednisone—Crohn's disease	0.000531	0.00149	CcSEcCtD
Boceprevir—Feeling abnormal—Mesalazine—Crohn's disease	0.000529	0.00148	CcSEcCtD
Boceprevir—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000525	0.00147	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—RASGRP1—Crohn's disease	0.000525	0.00185	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CARD9—Crohn's disease	0.000524	0.00185	CbGpPWpGaD
Boceprevir—Neuropathy peripheral—Prednisone—Crohn's disease	0.000522	0.00146	CcSEcCtD
Boceprevir—Hypersensitivity—Azathioprine—Crohn's disease	0.000519	0.00146	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—RBX1—Crohn's disease	0.000518	0.00183	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TAB1—Crohn's disease	0.000514	0.00181	CbGpPWpGaD
Boceprevir—Urticaria—Mesalazine—Crohn's disease	0.00051	0.00143	CcSEcCtD
Boceprevir—CTSV—Immune System—CCR6—Crohn's disease	0.000509	0.00179	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CCR6—Crohn's disease	0.000509	0.00179	CbGpPWpGaD
Boceprevir—Abdominal pain—Mesalazine—Crohn's disease	0.000508	0.00142	CcSEcCtD
Boceprevir—Body temperature increased—Mesalazine—Crohn's disease	0.000508	0.00142	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—ICAM1—Crohn's disease	0.000507	0.00179	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SEL1L—Crohn's disease	0.000505	0.00178	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NOD2—Crohn's disease	0.000505	0.00178	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—RASGRP1—Crohn's disease	0.000504	0.00178	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD79A—Crohn's disease	0.000502	0.00177	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—Crohn's disease	0.0005	0.00176	CbGeAlD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000488	0.00172	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000488	0.00172	CbGpPWpGaD
Boceprevir—Diarrhoea—Azathioprine—Crohn's disease	0.000482	0.00135	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—SOCS1—Crohn's disease	0.000476	0.00168	CbGpPWpGaD
Boceprevir—Hypersensitivity—Mesalazine—Crohn's disease	0.000473	0.00133	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—UBE2D1—Crohn's disease	0.000473	0.00167	CbGpPWpGaD
Boceprevir—Connective tissue disorder—Prednisone—Crohn's disease	0.00047	0.00132	CcSEcCtD
Boceprevir—Dizziness—Azathioprine—Crohn's disease	0.000466	0.00131	CcSEcCtD
Boceprevir—CTSL—Immune System—PTPN2—Crohn's disease	0.000465	0.00164	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTPN2—Crohn's disease	0.000465	0.00164	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NOD1—Crohn's disease	0.000464	0.00164	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCR9—Crohn's disease	0.000462	0.00163	CbGpPWpGaD
Boceprevir—Asthenia—Mesalazine—Crohn's disease	0.000461	0.00129	CcSEcCtD
Boceprevir—CTSV—Immune System—RBX1—Crohn's disease	0.00046	0.00162	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RBX1—Crohn's disease	0.00046	0.00162	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RIPK2—Crohn's disease	0.000458	0.00162	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—SOCS1—Crohn's disease	0.000457	0.00161	CbGpPWpGaD
Boceprevir—Pruritus—Mesalazine—Crohn's disease	0.000454	0.00127	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—UBE2D1—Crohn's disease	0.000454	0.0016	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—Crohn's disease	0.000454	0.0016	CbGpPWpGaD
Boceprevir—Vomiting—Azathioprine—Crohn's disease	0.000448	0.00126	CcSEcCtD
Boceprevir—Eye disorder—Prednisone—Crohn's disease	0.000447	0.00125	CcSEcCtD
Boceprevir—Rash—Azathioprine—Crohn's disease	0.000444	0.00125	CcSEcCtD
Boceprevir—Dermatitis—Azathioprine—Crohn's disease	0.000444	0.00125	CcSEcCtD
Boceprevir—Flushing—Prednisone—Crohn's disease	0.000444	0.00124	CcSEcCtD
Boceprevir—Headache—Azathioprine—Crohn's disease	0.000442	0.00124	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000441	0.00155	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RIPK2—Crohn's disease	0.00044	0.00155	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ITGA4—Crohn's disease	0.00044	0.00155	CbGpPWpGaD
Boceprevir—Diarrhoea—Mesalazine—Crohn's disease	0.000439	0.00123	CcSEcCtD
Boceprevir—Angiopathy—Prednisone—Crohn's disease	0.000434	0.00122	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CRP—Crohn's disease	0.000433	0.00153	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CRP—Crohn's disease	0.000433	0.00153	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RASGRP1—Crohn's disease	0.000432	0.00152	CbGpPWpGaD
Boceprevir—Immune system disorder—Prednisone—Crohn's disease	0.000432	0.00121	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GPR65—Crohn's disease	0.000429	0.00151	CbGpPWpGaD
Boceprevir—Arrhythmia—Prednisone—Crohn's disease	0.000427	0.0012	CcSEcCtD
Boceprevir—Dizziness—Mesalazine—Crohn's disease	0.000425	0.00119	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—TAB1—Crohn's disease	0.000423	0.00149	CbGpPWpGaD
Boceprevir—Alopecia—Prednisone—Crohn's disease	0.000423	0.00118	CcSEcCtD
Boceprevir—CTSK—Immune System—CCR6—Crohn's disease	0.000422	0.00149	CbGpPWpGaD
Boceprevir—Mental disorder—Prednisone—Crohn's disease	0.000419	0.00117	CcSEcCtD
Boceprevir—Nausea—Azathioprine—Crohn's disease	0.000419	0.00117	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000418	0.00147	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000418	0.00147	CbGpPWpGaD
Boceprevir—Erythema—Prednisone—Crohn's disease	0.000416	0.00117	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—Crohn's disease	0.000416	0.00117	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NOD2—Crohn's disease	0.000415	0.00147	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RASGRP1—Crohn's disease	0.000415	0.00146	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR4—Crohn's disease	0.000415	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR4—Crohn's disease	0.000415	0.00146	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—Crohn's disease	0.000414	0.00146	CbGpPWpGaD
Boceprevir—Vomiting—Mesalazine—Crohn's disease	0.000408	0.00114	CcSEcCtD
Boceprevir—Rash—Mesalazine—Crohn's disease	0.000405	0.00114	CcSEcCtD
Boceprevir—Dermatitis—Mesalazine—Crohn's disease	0.000405	0.00113	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000404	0.00143	CbGpPWpGaD
Boceprevir—CTSL—Immune System—UBE2D1—Crohn's disease	0.000403	0.00142	CbGpPWpGaD
Boceprevir—CTSV—Immune System—UBE2D1—Crohn's disease	0.000403	0.00142	CbGpPWpGaD
Boceprevir—Headache—Mesalazine—Crohn's disease	0.000402	0.00113	CcSEcCtD
Boceprevir—Vision blurred—Prednisone—Crohn's disease	0.000392	0.0011	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—SOCS1—Crohn's disease	0.000392	0.00138	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RIPK2—Crohn's disease	0.000391	0.00138	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RIPK2—Crohn's disease	0.000391	0.00138	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ITGA4—Crohn's disease	0.000391	0.00138	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ITGA4—Crohn's disease	0.000391	0.00138	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000389	0.00137	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Prednisone—Crohn's disease	0.000386	0.00108	CcSEcCtD
Boceprevir—CTSK—Immune System—PTPN2—Crohn's disease	0.000386	0.00136	CbGpPWpGaD
Boceprevir—Anaemia—Prednisone—Crohn's disease	0.000385	0.00108	CcSEcCtD
Boceprevir—Agitation—Prednisone—Crohn's disease	0.000383	0.00107	CcSEcCtD
Boceprevir—CTSS—Immune System—NOD1—Crohn's disease	0.000382	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ICAM1—Crohn's disease	0.000382	0.00135	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ICAM1—Crohn's disease	0.000382	0.00135	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL3—Crohn's disease	0.000381	0.00135	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL3—Crohn's disease	0.000381	0.00135	CbGpPWpGaD
Boceprevir—Nausea—Mesalazine—Crohn's disease	0.000381	0.00107	CcSEcCtD
Boceprevir—CTSK—Immune System—RBX1—Crohn's disease	0.000381	0.00134	CbGpPWpGaD
Boceprevir—Angioedema—Prednisone—Crohn's disease	0.00038	0.00107	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—SOCS1—Crohn's disease	0.000376	0.00133	CbGpPWpGaD
Boceprevir—Malaise—Prednisone—Crohn's disease	0.000375	0.00105	CcSEcCtD
Boceprevir—Vertigo—Prednisone—Crohn's disease	0.000374	0.00105	CcSEcCtD
Boceprevir—Syncope—Prednisone—Crohn's disease	0.000373	0.00105	CcSEcCtD
Boceprevir—CTSL—Immune System—RASGRP1—Crohn's disease	0.000369	0.0013	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RASGRP1—Crohn's disease	0.000369	0.0013	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—Crohn's disease	0.000368	0.0013	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—Crohn's disease	0.000368	0.0013	CbGpPWpGaD
Boceprevir—Loss of consciousness—Prednisone—Crohn's disease	0.000366	0.00103	CcSEcCtD
Boceprevir—CTSL—Immune System—TAB1—Crohn's disease	0.000361	0.00127	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TAB1—Crohn's disease	0.000361	0.00127	CbGpPWpGaD
Boceprevir—Hypertension—Prednisone—Crohn's disease	0.000359	0.00101	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CRP—Crohn's disease	0.000359	0.00126	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NOD2—Crohn's disease	0.000355	0.00125	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NOD2—Crohn's disease	0.000355	0.00125	CbGpPWpGaD
Boceprevir—Myalgia—Prednisone—Crohn's disease	0.000354	0.000994	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—Crohn's disease	0.000354	0.000994	CcSEcCtD
Boceprevir—Anxiety—Prednisone—Crohn's disease	0.000353	0.00099	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000352	0.000987	CcSEcCtD
Boceprevir—Discomfort—Prednisone—Crohn's disease	0.00035	0.000982	CcSEcCtD
Boceprevir—CTSS—Immune System—CCR6—Crohn's disease	0.000347	0.00122	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—Crohn's disease	0.000344	0.00121	CbGpPWpGaD
Boceprevir—Infection—Prednisone—Crohn's disease	0.000338	0.000946	CcSEcCtD
Boceprevir—CTSL—Immune System—SOCS1—Crohn's disease	0.000334	0.00118	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SOCS1—Crohn's disease	0.000334	0.00118	CbGpPWpGaD
Boceprevir—CTSK—Immune System—UBE2D1—Crohn's disease	0.000334	0.00118	CbGpPWpGaD
Boceprevir—Shock—Prednisone—Crohn's disease	0.000334	0.000937	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—Crohn's disease	0.000333	0.000934	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—Crohn's disease	0.000333	0.00117	CbGpPWpGaD
Boceprevir—Tachycardia—Prednisone—Crohn's disease	0.000332	0.00093	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—Crohn's disease	0.00033	0.000925	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—Crohn's disease	0.000328	0.000921	CcSEcCtD
Boceprevir—CTSK—Immune System—RIPK2—Crohn's disease	0.000324	0.00114	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ITGA4—Crohn's disease	0.000324	0.00114	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TYK2—Crohn's disease	0.000323	0.00114	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TYK2—Crohn's disease	0.000323	0.00114	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTPN2—Crohn's disease	0.000317	0.00112	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ICAM1—Crohn's disease	0.000317	0.00112	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL3—Crohn's disease	0.000316	0.00111	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000316	0.00111	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RBX1—Crohn's disease	0.000314	0.00111	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00031	0.000868	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—JAK2—Crohn's disease	0.000308	0.00109	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—JAK2—Crohn's disease	0.000308	0.00109	CbGpPWpGaD
Boceprevir—Insomnia—Prednisone—Crohn's disease	0.000307	0.000862	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR6—Crohn's disease	0.000306	0.00108	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RASGRP1—Crohn's disease	0.000306	0.00108	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisone—Crohn's disease	0.000305	0.000855	CcSEcCtD
Boceprevir—CTSK—Immune System—CD79A—Crohn's disease	0.000305	0.00107	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL18—Crohn's disease	0.000301	0.00106	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL18—Crohn's disease	0.000301	0.00106	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TAB1—Crohn's disease	0.000299	0.00105	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—Crohn's disease	0.000299	0.000838	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—Crohn's disease	0.000295	0.000828	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CRP—Crohn's disease	0.000295	0.00104	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NOD2—Crohn's disease	0.000294	0.00104	CbGpPWpGaD
Boceprevir—Fatigue—Prednisone—Crohn's disease	0.000293	0.000821	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—CD4—Crohn's disease	0.000292	0.00103	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—Crohn's disease	0.000292	0.00103	CbGpPWpGaD
Boceprevir—Constipation—Prednisone—Crohn's disease	0.000291	0.000815	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000284	0.001	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR4—Crohn's disease	0.000283	0.000998	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—Crohn's disease	0.000281	0.00099	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—Crohn's disease	0.000281	0.00099	CbGpPWpGaD
Boceprevir—Feeling abnormal—Prednisone—Crohn's disease	0.00028	0.000785	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—Crohn's disease	0.000278	0.000779	CcSEcCtD
Boceprevir—CTSK—Immune System—SOCS1—Crohn's disease	0.000277	0.000977	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RBX1—Crohn's disease	0.000277	0.000975	CbGpPWpGaD
Boceprevir—CTSS—Immune System—UBE2D1—Crohn's disease	0.000275	0.000971	CbGpPWpGaD
Boceprevir—Urticaria—Prednisone—Crohn's disease	0.00027	0.000757	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTGER4—Crohn's disease	0.000269	0.000949	CbGpPWpGaD
Boceprevir—Abdominal pain—Prednisone—Crohn's disease	0.000269	0.000753	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—Crohn's disease	0.000269	0.000753	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—TYK2—Crohn's disease	0.000268	0.000944	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2RA—Crohn's disease	0.000267	0.000942	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2RA—Crohn's disease	0.000267	0.000942	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RIPK2—Crohn's disease	0.000267	0.000941	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ITGA4—Crohn's disease	0.000267	0.000941	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ICAM1—Crohn's disease	0.000261	0.000919	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL3—Crohn's disease	0.00026	0.000918	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—JAK2—Crohn's disease	0.000256	0.000901	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000253	0.000893	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—Crohn's disease	0.000252	0.000889	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—Crohn's disease	0.000252	0.000889	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RASGRP1—Crohn's disease	0.000252	0.000888	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD79A—Crohn's disease	0.000251	0.000885	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—Crohn's disease	0.00025	0.000702	CcSEcCtD
Boceprevir—CTSK—Immune System—IL18—Crohn's disease	0.000249	0.000879	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TAB1—Crohn's disease	0.000246	0.000869	CbGpPWpGaD
Boceprevir—Asthenia—Prednisone—Crohn's disease	0.000244	0.000683	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—UBE2D1—Crohn's disease	0.000242	0.000855	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—Crohn's disease	0.000242	0.000854	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NOD2—Crohn's disease	0.000242	0.000853	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR4—Crohn's disease	0.000242	0.000852	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—Crohn's disease	0.000242	0.000852	CbGpPWpGaD
Boceprevir—Pruritus—Prednisone—Crohn's disease	0.00024	0.000674	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RIPK2—Crohn's disease	0.000235	0.000829	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD4—Crohn's disease	0.000233	0.00082	CbGpPWpGaD
Boceprevir—Diarrhoea—Prednisone—Crohn's disease	0.000232	0.000652	CcSEcCtD
Boceprevir—CTSL—Immune System—ICAM1—Crohn's disease	0.000232	0.000817	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ICAM1—Crohn's disease	0.000232	0.000817	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL3—Crohn's disease	0.000229	0.000809	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—Crohn's disease	0.000229	0.000806	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SOCS1—Crohn's disease	0.000228	0.000804	CbGpPWpGaD
Boceprevir—Dizziness—Prednisone—Crohn's disease	0.000225	0.00063	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RASGRP1—Crohn's disease	0.000222	0.000782	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2RA—Crohn's disease	0.000221	0.000781	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TYK2—Crohn's disease	0.000221	0.000778	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—Crohn's disease	0.000216	0.000606	CcSEcCtD
Boceprevir—Rash—Prednisone—Crohn's disease	0.000214	0.000601	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—Crohn's disease	0.000214	0.0006	CcSEcCtD
Boceprevir—Headache—Prednisone—Crohn's disease	0.000213	0.000597	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—JAK2—Crohn's disease	0.00021	0.000742	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CRP—Crohn's disease	0.000209	0.000737	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL18—Crohn's disease	0.000205	0.000724	CbGpPWpGaD
Boceprevir—Nausea—Prednisone—Crohn's disease	0.000202	0.000566	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SOCS1—Crohn's disease	0.000201	0.000708	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TLR4—Crohn's disease	0.0002	0.000706	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD4—Crohn's disease	0.000199	0.000703	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000194	0.000685	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ICAM1—Crohn's disease	0.000192	0.000677	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—Crohn's disease	0.000192	0.000675	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TYK2—Crohn's disease	0.000188	0.000664	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TYK2—Crohn's disease	0.000188	0.000664	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2RA—Crohn's disease	0.000182	0.000643	CbGpPWpGaD
Boceprevir—CTSV—Immune System—JAK2—Crohn's disease	0.00018	0.000633	CbGpPWpGaD
Boceprevir—CTSL—Immune System—JAK2—Crohn's disease	0.00018	0.000633	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000178	0.000629	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—Crohn's disease	0.000176	0.000622	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—Crohn's disease	0.000176	0.000622	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SMAD3—Crohn's disease	0.000173	0.000612	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CRP—Crohn's disease	0.000172	0.000607	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—Crohn's disease	0.00017	0.0006	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—Crohn's disease	0.00017	0.0006	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000167	0.000589	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—Crohn's disease	0.000165	0.000581	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2RA—Crohn's disease	0.000161	0.000566	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00016	0.000564	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00016	0.000564	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—Crohn's disease	0.000158	0.000557	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—Crohn's disease	0.000158	0.000557	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—Crohn's disease	0.000158	0.000557	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—Crohn's disease	0.000157	0.000555	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—Crohn's disease	0.000157	0.000555	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TYK2—Crohn's disease	0.000156	0.00055	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000155	0.000548	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000149	0.000525	CbGpPWpGaD
Boceprevir—CTSK—Immune System—JAK2—Crohn's disease	0.000149	0.000525	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—Crohn's disease	0.000146	0.000515	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—Crohn's disease	0.000141	0.000497	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—Crohn's disease	0.000132	0.000465	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—Crohn's disease	0.000132	0.000465	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—Crohn's disease	0.000131	0.000462	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—Crohn's disease	0.00013	0.000459	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TYK2—Crohn's disease	0.000128	0.000453	CbGpPWpGaD
Boceprevir—CTSS—Immune System—JAK2—Crohn's disease	0.000123	0.000432	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—Crohn's disease	0.00012	0.000424	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000117	0.000412	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—Crohn's disease	0.000116	0.00041	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TYK2—Crohn's disease	0.000113	0.000399	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000113	0.000397	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—Crohn's disease	0.000109	0.000385	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000108	0.000381	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JAK2—Crohn's disease	0.000108	0.000381	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—Crohn's disease	0.000108	0.00038	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—Crohn's disease	0.000107	0.000378	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.96e-05	0.000351	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTMR3—Crohn's disease	9.93e-05	0.00035	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—Crohn's disease	9.85e-05	0.000347	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—Crohn's disease	9.21e-05	0.000325	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—Crohn's disease	9.21e-05	0.000325	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—Crohn's disease	9e-05	0.000317	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G4F—Crohn's disease	8.81e-05	0.000311	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—Crohn's disease	7.92e-05	0.000279	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.9e-05	0.000279	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FADS1—Crohn's disease	7.74e-05	0.000273	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—Crohn's disease	7.63e-05	0.000269	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTMR3—Crohn's disease	7.49e-05	0.000264	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX4—Crohn's disease	7.24e-05	0.000255	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCKR—Crohn's disease	7e-05	0.000247	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—Crohn's disease	6.28e-05	0.000222	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FADS1—Crohn's disease	5.84e-05	0.000206	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—Crohn's disease	5.54e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX4—Crohn's disease	5.47e-05	0.000193	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.43e-05	0.000191	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	5.34e-05	0.000188	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCKR—Crohn's disease	5.28e-05	0.000186	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.62e-05	0.000163	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FADS1—Crohn's disease	3.6e-05	0.000127	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.59e-05	0.000126	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX4—Crohn's disease	3.37e-05	0.000119	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCKR—Crohn's disease	3.25e-05	0.000115	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—Crohn's disease	2.23e-05	7.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.95e-05	6.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—Crohn's disease	1.68e-05	5.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—Crohn's disease	1.47e-05	5.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—Crohn's disease	1.04e-05	3.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—Crohn's disease	9.06e-06	3.19e-05	CbGpPWpGaD
